Ying Zhao

6PUBLICATIONS
13CO-AUTHORS
Photography, video and lens-based practiceEpidemiological methodsPharmacogenomicsTheoretical quantum chemistryGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 13, 2025
Longer-term virologic outcomes on tenofovir-lamivudine-dolutegravir in second-line ART.

Jennifer K van Heerden, Ying Zhao, Claire M Keene

|Mar 03, 2025
Resistance to Dolutegravir in Treatment-experienced Patients in South Africa: A Retrospective Cohort Study.

Ying Zhao, Melanie Holtman, Vanessa Mudaly

|May 10, 2024
Virologic outcomes with tenofovir-lamivudine-dolutegravir in adults failing PI-based second-line ART.

Ying Zhao, Jacqueline Voget, Isaac Singini

|Oct 27, 2022
Dolutegravir for second-line treatment: Programmatic implications of new evidence.

Ying Zhao, Gary Maartens, Graeme Meintjes

|Aug 26, 2022
AntiRetroviral Therapy In Second-line: investigating Tenofovir-lamivudine-dolutegravir (ARTIST): protocol for a randomised controlled trial.

Ying Zhao, Claire Keene, Rulan Griesel

|Feb 17, 2022
Risk of Immune Reconstitution Inflammatory Syndrome With Integrase Inhibitors Versus Other Classes of Antiretrovirals: A Systematic Review and Meta-analysis of Randomized Trials.

Ying Zhao, Ameer Hohlfeld, Phiona Namale

Pageof 1

Frequent Collaborators

4 joint publications

Gary Maartens

3 joint publications

Graeme Meintjes

2 joint publications

Rulan Griesel

2 joint publications

Zaayid Omar